Morbidity

Percent prevalence of chronic conditions among users of chronic drugs program, 2016*

Chronic conditions	Prevalence
Cardiovascular diseases, atherosclerosis, coagulation problems and hypertension	47%
Diabetes	15%
Ulcers	10%
High cholesterol level	10%
Other diseases (Rheumatism, uric acid, glaucoma, osteoporosis...)	8%
Diseases of the nervous system	3%
Epilepsy	3%
Thyroid Problems	2%
Asthma	2%

*For previous years check the Statistical Bulletins' page

Newly reported HIV cases, 2020

Newly reported HIV cases,2021

Newly reported HIV cases, 2022

New reported HIV cases,2023

New reported HIV cases,2024

https://www.moph.gov.lb/userfiles/files/Prevention/TB%20Program/NTP-NAP%20Annual%20Report-2024.pdf

Number of Measles cases

	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023
Measles	9	1,760	235	39	44	126	952	1070	-	28	95	351

Source :MoPH 01/09/2024

Number of Tuberculosis cases*

Tuberculosis cases	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total number of cases	630	689	682	666	657	632	668	760	656	466	510	510	540
Number of Lebanese cases	330	341	337	312	305	271	254	288	277	233	263	249	225
Number of Non-Lebanese cases	300	348	345	354	352	361	414	472	379	233	247	261	315

*MOPH National Tuberculosis Program 01/05/2025

The trend in Tuberculosis cases by Nationality between 2019 and 2024

...

All

ATC	Name	B/G	Ingredients	Dosage	Form	Price
L04AX04	LENALIDOMIDE SPC	G	Lenalidomide - 10mg	10mg	Capsule, hard	75,120,146 L.L
L04AX04	LENALIDOMIDE STRAGEN	G	Lenalidomide - 10mg	10mg	Capsule	33,314,752 L.L
L04AX04	LENOMA	G	Lenalidomide - 10mg	10mg	Capsule, hard	14,449,637 L.L
L04AX04	LENOMA	G	Lenalidomide - 15mg	15mg	Capsule, hard	L.L
L04AX04	LEDOBOOK 15	G	Lenalidomide - 15mg	15mg	Capsule	62,230,245 L.L
L04AX04	LENALIDOMIDE ARROW	G	Lenalidomide - 15mg	15mg	Capsule	26,651,802 L.L
L04AX04	LENALIDOMIDE NEAPOLIS	G	Lenalidomide - 15mg	15mg	Capsule	76,209,421 L.L
L04AX04	LENALIDOMIDE STRAGEN	G	Lenalidomide - 15mg	15mg	Capsule	33,314,752 L.L
L04AX04	LENOMA	G	Lenalidomide - 15mg	15mg	Capsule, hard	15,241,884 L.L
L04AX04	LENOMA	G	Lenalidomide - 25mg	25mg	Capsule, hard	L.L
L04AX04	LEDOBOOK 25	G	Lenalidomide - 25mg	25mg	Capsule	67,887,540 L.L
L04AX04	LENALIDOMIDE ARROW	G	Lenalidomide - 25mg	25mg	Capsule	26,651,802 L.L
L04AX04	LENALIDOMIDE NEAPOLIS	G	Lenalidomide - 25mg	25mg	Capsule	76,719,234 L.L
L04AX04	LENALIDOMIDE SPC	G	Lenalidomide - 25mg	25mg	Capsule, hard	87,161,381 L.L
L04AX04	LENALIDOMIDE STRAGEN	G	Lenalidomide - 25mg	25mg	Capsule	33,314,752 L.L
L04AX04	LENOMA	G	Lenalidomide - 25mg	25mg	Capsule, hard	15,343,847 L.L
L04AX04	LENALIDOMIDE ARROW	G	Lenalidomide - 5mg	5mg	Capsule	26,651,802 L.L
L04AX04	LENALIDOMIDE NEAPOLIS	G	Lenalidomide - 5mg	5mg	Capsule	68,908,116 L.L
L04AX04	LENALIDOMIDE SPC	G	Lenalidomide - 5mg	5mg	Capsule, hard	71,647,217 L.L
L04AX04	LENALIDOMIDE STRAGEN	G	Lenalidomide - 5mg	5mg	Capsule	33,314,752 L.L
L04AX04	LENOMA	G	Lenalidomide - 5mg	5mg	Capsule, hard	68,908,116 L.L
L01EX08	LENVIMA	B	Lenvatinib - 10mg	10mg	Capsule, hard	124,450,304 L.L
L01EX08	LENVIMA	B	Lenvatinib - 10mg	10mg	Capsule, hard	L.L
L01EX08	LENVIMA	B	Lenvatinib - 4mg	4mg	Capsule, hard	124,450,304 L.L
L01EX08	LENVIMA	B	Lenvatinib - 4mg	4mg	Capsule, hard	L.L
C08CA13	LERCADIP	B	Lercanidipine HCl - 10mg	10mg	Tablet, film-scored	1,021,320 L.L
C08CA13	LERCADIP	B	Lercanidipine HCl - 20mg	20mg	Tablet, film-scored	1,679,803 L.L
L02BG04	LEFFTARA	G	Letrozole - 2.5mg	2.5mg	Tablet, film coated	2,060,111 L.L
L02BG04	LETROZOLE ARROW	G	Letrozole - 2.5mg	2.5mg	Tablet, film coated	2,402,790 L.L
L02BG04	LETROZOLE ARROW LAB	G	Letrozole - 2.5mg	2.5mg	Tablet, coated	2,000,981 L.L

...